Craig Eng

Craig Eng is a seasoned professional in pharmacovigilance and drug safety, currently serving as Sr. Director of Pharmacovigilance at 4D Molecular Therapeutics since August 2023. Prior to this role, Eng held multiple senior positions at Santen, including Sr. Director and Head of Pharmacoepidemiology, and Sr. Director of Global Safety Vigilance Operations from April 2017 to December 2023. Eng’s extensive experience includes roles such as Director of Drug Safety at BioMarin Pharmaceutical Inc. and Senior Safety Scientist Lead at Genentech. Eng has also played key roles at InterMune, Cell Genesys, and SangStat Medical Corporation. Eng holds a PharmD from the University of California, San Francisco, and a BS in Microbiology from UCLA.